Pharose Remedies (Unit-Ii) Private Limited - Company Profile

It is a paper private limited company based in Jalandhar - I, Punjab, India, established in 2023.
2023 Jalandhar - I, Punjab, India Struck Off
Last Updated:
About Pharose Remedies (Unit-Ii) Private Limited

Pharose Remedies (Unit-Ii) Private Limited, a struck off private limited company, was established on 29 December 2023 in Jalandhar - I, Punjab, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21002PB2023PTC060364. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shalu Jain (Non- Individual Subscriber), Pardeep Jain (Director), Nand Kishore Jain (Director). It is based at E F-378, Mandi Road,, Jalandhar - I, Punjab, 144001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21002PB2023PTC060364

  • Registration Number

    060364

  • Incorporation Date

    29 December 2023

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 1 Month
Company report

Pharose Remedies (Unit-Ii) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pharose Remedies (Unit-Ii) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pharose Remedies (Unit-Ii) Private Limited?
Current Directors
Name Designation Appointment Date Status
Shalu Jain Non- Individual Subscriber 29 Dec 2023 Current
Pardeep Jain Director 29 Dec 2023 Current
Nand Kishore Jain Director 29 Dec 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pharose Remedies (Unit-Ii).

Enhance accessibility to Pharose Remedies (Unit-Ii)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Pharose Remedies (Unit-Ii) revenue growth over time
Pharose Remedies (Unit-Ii) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pharose Remedies (Unit-Ii)?

Unlock access to Pharose Remedies (Unit-Ii)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Pharose Remedies (Unit-Ii)?

Unlock and access historical data on people associated with Pharose Remedies (Unit-Ii), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pharose Remedies (Unit-Ii), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharose Remedies (Unit-Ii)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pharose Remedies (Unit-Ii)
Recent Activity within the Organization
  • Director Appointment

    The activity Shalu Jain was appointed as a Non- Individual Subscriber was appointed as a Non- Individual Subscriber on 29 Dec 2023 & has been associated with this company since 2 years 1 month . was completed.

  • Director Appointment

    The activity Pardeep Jain was appointed as a Director was appointed as a Director on 29 Dec 2023 & has been associated with this company since 2 years 1 month . was completed.

  • Director Appointment

    The activity Nand Kishore Jain was appointed as a Director was appointed as a Director on 29 Dec 2023 & has been associated with this company since 2 years 1 month . was completed.

  • Company Incorporation

    Progress on Pharose Remedies (Unit-Ii) Private Limited was registered on 29 Dec 2023 with Roc Chandigarh & aged 2 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pharose Remedies (Unit-Ii) Private Limited?

The CIN of Pharose Remedies (Unit-Ii) Private Limited is U21002PB2023PTC060364.

Where is Pharose Remedies (Unit-Ii) Private Limited headquartered?

Pharose Remedies (Unit-Ii) Private Limited is headquartered at E F-378, Mandi Road,, Jalandhar - I, Punjab, 144001.

When was Pharose Remedies (Unit-Ii) Private Limited incorporated?

Pharose Remedies (Unit-Ii) Private Limited was incorporated on 29 December 2023.

Who are the current directors of Pharose Remedies (Unit-Ii) Private Limited?

The current directors of Pharose Remedies (Unit-Ii) Private Limited are

What is the primary industry of Pharose Remedies (Unit-Ii) Private Limited?

The primary industry of Pharose Remedies (Unit-Ii) Private Limited is Paper.

Is Pharose Remedies (Unit-Ii) Private Limited a listed company?

Pharose Remedies (Unit-Ii) Private Limited is unlisted.

What is the capital structure of Pharose Remedies (Unit-Ii) Private Limited?

The authorized capital of Pharose Remedies (Unit-Ii) Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available